Federal award
CLEVELAND BIOLABS, INC.
W81XWH15C0101
Contract
Obligated and Ceiling
- Obligated (net)
- $3,558,603.15
- Ceiling (potential value, not spending)
- $3,558,603.15
- Current value
- $3,558,603.15
- Gross positive obligations
- $9,226,454.64
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- CLEVELAND BIOLABS, INC. · J223MEGF2LP1
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- CLEVELAND BIOLABS, INC. · J223MEGF2LP1
- Awarding agency
- Department of War · sub-agency 2100 · office W81XWH
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- AN13 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
- Industry (NAICS)
- 541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
- PIID
- W81XWH15C0101
- Award type code
- D
- Actions
- 9 · Sep 1, 2015 to Nov 12, 2020
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Nov 12, 2020 | FY2021 | P00008 | C | $0.00 | — |
| Sep 29, 2020 | FY2020 | P00007 | C | −$604,262.49 | — |
| Jul 30, 2020 | FY2020 | P00006 | D | −$5,063,589.00 | — |
| Mar 18, 2020 | FY2020 | P00005 | D | $0.00 | — |
| Feb 28, 2019 | FY2019 | P00004 | M | $0.00 | — |
| Sep 14, 2017 | FY2017 | P00003 | M | $0.00 | — |
| Oct 14, 2016 | FY2017 | P00002 | M | $0.00 | — |
| Oct 4, 2016 | FY2017 | P00001 | A | $0.00 | — |
| Sep 1, 2015 | FY2015 | 0 | — | $9,226,454.64 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.